Skip to content

Glucose and Fructose Stimulated Brain Activity in Obese Subjects Before and After Bariatric Surgery

Glucose and Fructose Stimulated Brain Activity in Obese Subjects Before and After Bariatric Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02902224
Enrollment
15
Registered
2016-09-15
Start date
2014-04-30
Completion date
2016-08-31
Last updated
2016-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exploratory Behavior

Brief summary

The objective is to investigate neuro-anatomical correlates of the regulation of energy intake by means of functional MRI before and after bariatric surgery. Administration of glucose as well as fructose is followed by functional brain MRI, and findings are correlated with serum glucagon-like peptide 1 (GLP-1) levels as an endogenous satiety signal in obese humans.

Interventions

DIETARY_SUPPLEMENTTap water

300ml tap water via nasogastric tube

DIETARY_SUPPLEMENTGlucose

300ml tap water with 75g glucose via nasogastric tube

DIETARY_SUPPLEMENTFructose

300ml tap water with 25g fructose via nasogastric tube

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* right-handed * morbidly obese patients * scheduled for bariatric surgery

Exclusion criteria

* Diabetes mellitus * cardiovascular disease * neurologic or psychiatric disorder

Design outcomes

Primary

MeasureTime frame
Functional magnetic resonance imaging (fMRI) in healthy, obese volunteers while they performed a working memory task: changes in cerebral blood flowchanges from baseline to one hour after treatment

Secondary

MeasureTime frame
Changes in plasma glucoseChanges from baseline to one hour after treatment
Changes in plasma insulinChanges from baseline to one hour after treatment
Changes in Plasma GLP-1Changes from baseline to one hour after treatment

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026